Exome Sequencing as a First Tier Test for Congenital Anomalies or Neurodevelopmental Disorders with David Miller, MD, PhD

  • Details to come.

Director, Neurofibromatosis Program, Boston Children's Hospital; Assistant Professor, Harvard Medical School

David T. Miller, MD, PhD, FAAP, FACMG is an Associate Professor of Pediatrics at Harvard Medical School and Director of the Multidisciplinary Neurofibromatosis (NF) Clinic and NF Research Initiative (NFRI) at Boston Children’s Hospital. Dr. Miller is a practicing Medical Geneticist, both in direct patient care and laboratory genetics. His clinical, research, and teaching activities are focused on clinical expertise and innovation in delivering clinically effective and appropriate diagnostic genetic testing services. He has led or served on several national committees and advisory boards focused on best practices for clinical genetics and genetic testing, including: Co-Chair of the ClinGen Gene Curation Expert Panel for Autism and Intellectual Disability; Chair of ACMG’s Professional Practice and Guidelines Committee; Co-Chair of ACMG’s Secondary Findings Maintenance Working Group; Member of ACMG’s Evidence-Based Medicine Working Group; Member of ACMG’s Topic Selection Committee. He currently serves as Deputy Editor of Genetics in Medicine.

After receiving his MD and PhD from Washington University School of Medicine in St. Louis, he completed a residency in Pediatrics at Yale-New Haven Hospital, and residency/fellowship in Medical Genetics and Clinical Molecular Genetics at Harvard Medical School. He is board-certified in Clinical Genetics and Clinical Molecular Genetics.

Register Now
  • Wed, July 15, 2020
  • 10:00am PDT
  • Duration: 1 hour
  • C.E.U.
    1 Category 1 Contact Hour
  • P.A.C.E. 1 unit

Webinar Newsletter

Subscribe to receive notifications for future webinars.

Search Results

Start your search...